BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32904472)

  • 41. Serum oxytocin concentrations in elective caesarean delivery: a randomized comparison of three infusion regimens.
    Yamaguchi ET; Cardoso MM; Torres ML; Nascimento RC; Ribeiro MC; Frerichs E; Payen D
    Int J Obstet Anesth; 2011 Jul; 20(3):224-8. PubMed ID: 21641198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxytocin infusion dose-response to maintain uterine tone in obese elective cesarean patients: a randomized controlled trial.
    Yan QF; Ai L; Huang YM; Wang J; Xiao F; Xu H; Tang XD
    Front Pharmacol; 2024; 15():1361953. PubMed ID: 38698824
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of initiating intravenous oxytocin infusion before uterine incision on the blood loss during elective cesarean section: a randomized clinical trial.
    Abdelaleem AA; Abbas AM; Thabet AL; Badran E; El-Nashar IH
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3723-3728. PubMed ID: 29712515
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of co-administration of intravenous calcium chloride and oxytocin on maternal hemodynamics and uterine tone following cesarean delivery: a double-blinded, randomized, placebo-controlled trial.
    Farber MK; Schultz R; Lugo L; Liu X; Huang C; Tsen LC
    Int J Obstet Anesth; 2015 Aug; 24(3):217-24. PubMed ID: 25935422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
    Rath W
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth.
    Widmer M; Piaggio G; Nguyen TMH; Osoti A; Owa OO; Misra S; Coomarasamy A; Abdel-Aleem H; Mallapur AA; Qureshi Z; Lumbiganon P; Patel AB; Carroli G; Fawole B; Goudar SS; Pujar YV; Neilson J; Hofmeyr GJ; Su LL; Ferreira de Carvalho J; Pandey U; Mugerwa K; Shiragur SS; Byamugisha J; Giordano D; Gülmezoglu AM;
    N Engl J Med; 2018 Aug; 379(8):743-752. PubMed ID: 29949473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomised double-blind trial of minimal bolus doses of oxytocin for elective caesarean section under spinal anaesthesia: Optimal or not?
    Joseph J; George SK; Daniel M; Ranjan RV
    Indian J Anaesth; 2020 Nov; 64(11):960-964. PubMed ID: 33487681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.
    El Behery MM; El Sayed GA; El Hameed AA; Soliman BS; Abdelsalam WA; Bahaa A
    J Matern Fetal Neonatal Med; 2016; 29(8):1257-60. PubMed ID: 25946576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 μg and 100 μg.
    Tabl S; Balki M; Downey K; Tomlinson G; Farine D; Seaward G; Carvalho JCA
    Anaesthesia; 2019 Feb; 74(2):190-196. PubMed ID: 30506558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Weight-based oxytocin infusion for preventing uterine atony during caesarean delivery in non-labouring patients: A dose-response study.
    Tyagi S; Tyagi A; Rashmi S; Mohta M; Gupta B
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):497-503. PubMed ID: 36846888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.
    Leduc D; Senikas V; Lalonde AB;
    J Obstet Gynaecol Can; 2009 Oct; 31(10):980-993. PubMed ID: 19941729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous oxytocin in patients undergoing elective cesarean section.
    Sarna MC; Soni AK; Gomez M; Oriol NE
    Anesth Analg; 1997 Apr; 84(4):753-6. PubMed ID: 9085952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial.
    Al Zubaidi S; Alhaidari T
    J Perinat Med; 2022 Feb; 50(2):150-156. PubMed ID: 34535047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbetocin versus oxytocin following vaginal and Cesarean delivery: a before-after study.
    Ben Tareef A; Downey K; Ma B; Whittle WL; Carvalho JCA
    Can J Anaesth; 2022 Jan; 69(1):97-105. PubMed ID: 34713434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
    Westhoff G; Cotter AM; Tolosa JE
    Cochrane Database Syst Rev; 2013 Oct; (10):CD001808. PubMed ID: 24173606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.
    Adnan N; Boland F; Murphy DJ
    Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
    Lee AI; Wong CA; Healy L; Toledo P
    Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An observational cohort study of 3 units versus 5 units slow intravenous bolus oxytocin in women undergoing elective caesarean delivery.
    Terblanche N; Otahal P; Messmer A; Wright P; Patel S; Nathan K; Sharman JE
    J Physiol Pharmacol; 2017 Aug; 68(4):547-553. PubMed ID: 29151071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section.
    Beiranvand S; Karimi A; Vahabi S; Amin-Bidokhti A
    Curr Clin Pharmacol; 2019; 14(3):208-213. PubMed ID: 31124424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.